The DOI matches its Crossref record; 889 of the 893 references it cites were found in a registry or an index, and 4 are not checked yet.
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Open accessAbstract
The individual reviewers' relationships with industry information is available in Appendix 2.This document was approved for publication by the governing bodies of the ASA and the AHA.It was reviewed for evidence-based integrity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Individuals with CKM stage 1 due to overweight and obesity are at increased risk for developing metabolic risk factors and CKD compared with those who have a normal weight without risk factors (CKM stage 0).5,6,41”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even in the absence of these metabolic risk factors, excess weight is associated with increased cardiovascular risk, particularly for HF.6,42”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a particular focus on preventing the development of excess and dysfunctional adipose tissue because the emergence of metabolic risk factors from youth and young adulthood into middle age is primarily related to weight gain with aging.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For adults with overweight or obesity who have significant barriers to participating in multicomponent behavioral weight loss interventions, self-directed digital health solutions can be beneficial to promote weight loss for CKM syndrome risk reduction.5–7”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among patients with CKM stage 1 to 3 and obesity without an adequate weight loss response to lifestyle modification, with or without the use of adjunctive obesity pharmacotherapies, MBS can be beneficial to facilitate weight loss and to mitigate CKM syndrome progression.1–8”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MBS has efficacy among individuals with a BMI ≥35 kg/m2 regardless of the presence of comorbidities and can be beneficial in patients with T2D with a threshold BMI of 30 kg/m2.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glycemia consistently improves with use of these agents, with some evidence for preventing progression to diabetes in those with insulin resistance.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MBS has efficacy among individuals with a BMI ≥35 kg/m2 regardless of the presence of comorbidities and can be beneficial in patients with T2D with a threshold BMI of 30 kg/m2.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Counseling on dietary or combined dietary and exercise modifications effectively facilitates weight loss in postpartum women with GDM.6,19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“RASi provide BP control and kidney and cardiovascular protection6 and are therefore preferred in patients with CKD and albuminuria.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical trials and meta-analyses of SGLT2i in patients with CKD and T2D or CKD and UACR ≥200 mg/g without T2D have shown a significant reduction in risks of losing kidney function, kidney failure, cardiovascular death, and HF hospitalization when compared with placebo.5–7”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of subclinical atherosclerosis (eg, elevated CAC) is associated with an increased cardiovascular risk among those with CKM risk factors (eg, diabetes, CKD).5–7”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A heart-healthy diet and regular physical activity remain the cornerstones of therapy in patients with T2D and ASCVD, with demonstrated benefits for CKM risk profiles.5–12”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, habitual physical activity, including activities that reduce sedentary time, aerobic physical activity, and resistance training, are associated with improvements in several CKM risk factors (HbA1c, waist circumference, fat percentage, BP) and mortality.5–12”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MBS is associated with a lower risk of incident major adverse liver outcomes and MACE in large cohort studies.6,24,25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a 60% increased risk of stroke recurrence.35”
From Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Standard stroke care includes medical treatment, routine stroke therapy, and rehabilitative exercises, as outlined in the basic guidelines [35,36].”
From Smartphone-Based Speech Therapy for Poststroke Dysarthria: Pilot Randomized Controlled Trial Evaluating Efficacy and Feasibility (2024) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, current guidelines recommend short-term dual antiplatelet therapy after high-risk transient ischemic attack and minor stroke (198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [198]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, owing to the chronicity of obesity and multiple compensatory changes in metabolism, hunger, and satiety promoting weight recidivism,6 frequent and long-term engagement and behavioral support for lifestyle modification are needed for optimal effectiveness.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, as per clinical guidelines, persistently elevated triglycerides are considered a risk enhancer for ASCVD.2,4–6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CAC assessment improves prediction of ASCVD4,5 and selection of patients for treatment with aggressive ASCVD risk factor modification (ie, statin therapy).6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CorCal (Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of CAC Screening, in Preventing Future MACE)6 randomized 601 primary prevention patients to CAC (n=302) or risk calculator guidance (n=299) for primary prevention; the CAC arm had a greater reclassification of risk compared with the group using a risk calculator.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“At 1 year, statin adherence was superior, low-density lipoprotein cholesterol (LDL-C) levels were lower, and estimated costs were similar or reduced in the CAC arm.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“At 1 year, statin adherence was superior, low-density lipoprotein cholesterol (LDL-C) levels were lower, and estimated costs were similar or reduced in the CAC arm.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“At 1 year, statin adherence was superior, low-density lipoprotein cholesterol (LDL-C) levels were lower, and estimated costs were similar or reduced in the CAC arm.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Once obesity is established, multiple compensatory mechanisms impacting metabolism, hunger, and satiety are triggered in the setting of intentional weight loss, which commonly result in weight regain.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In EMPA-Kidney, the risk reduction for the primary outcome (a composite of progression of kidney disease or death from cardiovascular causes) with empagliflozin compared with placebo was larger among patients with higher UACR (UACR ≥30–300: HR, 0.91; 95% CI, 0.65–1.26 versus UACR ≥300: HR, 0.67; 95% CI, 0.58–0.78).6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, the rate of eGFR decline after the initial decrease was slower in the empagliflozin group than in the placebo group in all key subgroups, including in the subgroup of patients with a UACR <30 mg/g.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Simulation studies suggest that combinations of CKM therapies may have additive benefits for heart and kidney protection.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the SELECT trial,6 17 604 participants with BMI ≥27 kg/m2 and established ASCVD (prior MI, stroke, or symptomatic PAD), and without T2D, end-stage kidney disease, or dialysis, were enrolled. The trial demonstrated a 20% reduction in risk of the composite primary endpoint of cardiovascular death, nonfatal MI, or nonfatal stroke for those treated with semaglutide (2.4 mg) as compared with placebo”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A single-arm 15-week pragmatic weight management program (weekly consultations with exercise specialists, dietitians, and behavioral specialists), achieved a mean weight loss of 8.1 kg (−6.7%) for patients with obesity-related HFpEF.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among patients with HFrEF, RASi improves both HF outcomes and risk for worsening kidney disease in several clinical trials.1–8,28”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A directionally similar reduction in risk of the cardiovascular outcome (cardiovascular death, nonfatal MI, nonfatal stroke, or hospitalization for HF) was observed in a subgroup with CKD G4 in the FIDELITY meta-analysis of finerenone in diabetic patients, but this was nonsignificant and requires further investigation.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Metabolic and bariatric surgery causes remission of MASLD, even in advanced stages.6,24,25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Hyperkalemia was more frequent in those with CKD G4 treated with finerenone.6”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abdominal adiposity is one of the strongest VTE risk factors.3,5–7”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Accordingly, many guidelines now recommend the addition of GLP-1RAs to ongoing antihyperglycemic regimens to lower the risk of stroke in type 2 diabetes.”
From Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists (2022) · cites this paper as [7]
In the citing paper
“the American Heart Association/American Stroke Association guideline suggests GLP-1RAs as second-line to metformin regardless of baseline HbA1c in individuals with established atherosclerotic CVD to avoid further vascular events 7”
From Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists (2022) · cites this paper as [7]
In the citing paper
“In the same vein, the 2020 Canadian Stroke Best Practices update for secondary prevention of stroke, 8 2021 Spanish Society of Neurology consensus statement, 9 2021 American Heart Association/American Stroke Association Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack, 7 and the Diabetes, Cardiorenal, and Metabolic Diseases Multispecialty Task Force 55”
From Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists (2022) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 893
Zaidat, O. O., Fitzsimmons, B., Woodward, B. K., Wang, Z., Killer‐Oberpfalzer, M., Wakhloo, A. K., Gupta, R. G., Kirshner, H. S., Megerian, J. T., Lesko, J. P., et al. (2015) · JAMA · doi:10.1001/jama.2015.1693 · Cited by 628
Magnani, J. W., Mujahid, M. S., Aronow, H. D., Cené, C. W., Dickson, V. V., Havranek, E. P., Morgenstern, L. B., Paasche‐Orlow, M. K., Pollak, A. W., & Willey, J. Z. (2018) · Circulation · doi:10.1161/cir.0000000000000579 · Cited by 626
Antithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C. J., Fremes, S. E., Rubens, F. D., & Teoh, K. (2012) · CHEST Journal · doi:10.1378/chest.11-2305 · Cited by 623
Mahr, A., Jover, J. Á., Spiera, R., Hernández‐García, C., Fernández‐Gutiérrez, B., LaValley, M. P., & Merkel, P. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22754 · Cited by 617
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
Johnston, S. C., Amarenco, P., Denison, H., Evans, S. R., Himmelmänn, A., James, S. K., Knutsson, M., Ladenvall, P., Molina, C. A., & Wang, Y. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916870 · Cited by 612
Complications of Diagnostic Cerebral Angiography: Evaluation of 19 826 Consecutive Patients 1
Kaufmann, T. J., Huston, J., Mandrekar, J. N., Schleck, C. D., Thielen, K. R., & Kallmes, D. F. (2007) · Radiology · doi:10.1148/radiol.2433060536 · Cited by 603
Bernhardt (2004) · doi:10.1161/01.str.0000120727.40792.40 · Cited by 593
Time Course of Sleep-related Breathing Disorders in First-Ever Stroke or Transient Ischemic Attack
Parra, O., Arboix, A., Bechich, S., García‐Eroles, L., Montserrat, J. M., LÓPEZ, J. A., Ballester, E., GUERRA, J. M., & Jj, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9903139 · Cited by 592
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Lee, P. H., Song, J., Kim, J. S., Heo, R., Lee, S., Kim, D., Song, J.-M., Kang, D., Kwon, S. U., Kang, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.046 · Cited by 591
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B. L., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202299 · Cited by 590
Salt Reduction to Prevent Hypertension and Cardiovascular Disease
He, F. J., Tan, M., Ma, Y., & MacGregor, G. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.055 · Cited by 589
FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01340.x · Cited by 585
Echocardiographically Documented Mitral-Valve Prolapse
Nishimura, R. A., McGoon, M. D., Shub, C., Miller, F. A., Ilstrup, D. M., & Tajik, A. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132101 · Cited by 584
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
Amarenco, P., Js, K., Labreuche, J., Charles, H., Abtan, J., Béjot, Y., Cabrejo, L., Jk, C., Ducrocq, G., Giroud, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910355 · Cited by 581
Villiger, P. M., Adler, S., Kuchen, S., Wermelinger, F., Dan, D., Fiege, V., Bütikofer, L., Seitz, M., & Reichenbach, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00560-2 · Cited by 577
Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
The French Study of Aortic Plaques in Stroke Group (1996) · New England Journal of Medicine · doi:10.1056/nejm199605093341902 · Cited by 567
The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke
Amarengo, P., Duyckaerts, C. J., Tzourio, C., Hénin, D., Bousser, M., & Hauw, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260402 · Cited by 565
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Grossman, D. C., et al. (2018) · JAMA · doi:10.1001/jama.2018.13022 · Cited by 563
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Dangas, G., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Makkar, R., Herrmann, H. C., Giustino, G., Baldus, S. E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911425 · Cited by 562
Hoffman, G. S., Cid, M. C., Rendt, K. E., Merkel, P. A., Weyand, C. M., Stone, J. H., Salvarani, C., Xu, W., Visvanathan, S., & Rahman, M. U. (2007) · PubMed · doi:10.7326/0003-4819-146-9-200705010-00004 · Cited by 557
The United States Registry for Fibromuscular Dysplasia
Olin, J. W., Froehlich, J. B., Gu, X., Bacharach, J. M., Eagle, K. A., Gray, B. H., Jaff, M. R., Kim, E. S. H., Mace, P. D., Matsumoto, A. H., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.091223 · Cited by 556
Embolic Stroke of Undetermined Source
Hart, R. G., Catanese, L., Perera, K. S., Ntaios, G., & Connolly, S. J. (2017) · Stroke · doi:10.1161/strokeaha.116.016414 · Cited by 555
Chiavaroli, L., Viguiliouk, E., Nishi, S., Blanco Mejia, S., Rahelić, D., Kahleová, H., Salas-Salvadó, J., Kendall, C., & Sievenpiper, J. (2019) · Nutrients · doi:10.3390/nu11020338 · Cited by 548
García-Cabrera, E., Fernández-Hidalgo, N., Almirante, B., Ivanova-Georgieva, R., Noureddine, M., Plata, A., Lomas, J. M., Gálvez-Acebal, J., Hidalgo-Tenorio, C., Ruíz-Morales, J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000813 · Cited by 546
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A. G. G., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 546
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
DeBaun, M. R., Gordon, M., McKinstry, R. C., Noetzel, M. J., White, D. A., Sarnaik, S. A., Meier, E. R., Howard, T. H., Majumdar, S., Inusa, B. P. D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401731 · Cited by 545
The varicella zoster virus vasculopathies
Nagel, M. A., Cohrs, R. J., Mahalingam, R., Wellish, M., Forghani, B., Schiller, A. U., Safdieh, J. E., Kamenkovich, E., Ostrow, L. W., Levy, M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304747.38502.e8 · Cited by 545
Sandset, E. C., Bath, P. M., Boysen, G., Jatuzis, D., Kõrv, J., Lüders, S., Murray, G. D., Richter, P. S., Roine, R. O., Terént, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60104-9 · Cited by 541
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00475 · Cited by 537
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
Johnston, S. C., Amarenco, P., Albers, G. W., Denison, H., Easton, J. D., Evans, S. R., Held, P., Jonasson, J., Minematsu, K., Molina, C. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603060 · Cited by 530
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
Rashid, P. A., Leonardi‐Bee, J., & Bath, P. M. (2003) · Stroke · doi:10.1161/01.str.0000092488.40085.15 · Cited by 529
Qaseem, A., Dallas, P., Owens, D. K., Starkey, M., Holty, J.-E. C., & Shekelle, P. (2014) · Annals of Internal Medicine · doi:10.7326/m12-3187 · Cited by 526
Racial-Ethnic Disparities in Stroke Care: The American Experience
Cruz‐Flores, S., Rabinstein, A. A., Biller, J., Elkind, M. S. V., Griffith, P. A., Gorelick, P. B., Howard, G., Leira, E. C. C., Morgenstern, L. B., Ovbiagele, B. I., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182213e24 · Cited by 525
Self-citationBody mass index and the risk of stroke in men
Kurth, T., Gaziano, J. M., Berger, K., Kase, C. S., Rexrode, K. M., Cook, N. R., Buring, J. E., & Manson, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2557 · Cited by 524
Frequency of Sleep Apnea in Stroke and TIA Patients: A Meta-analysis
Johnson, K. G., & Johnson, D. C. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27760 · Cited by 523
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01041-7 · Cited by 515
Avan, A., Digaleh, H., Di Napoli, M., Stranges, S., Behrouz, R., Shojaeianbabaei, G., Amiri, A., Tabrizi, R., Mokhber, N., Spence, J. D., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1397-3 · Cited by 514
Prevalence of diagnosed diabetes in adults by diabetes type – United States, 2016
Bullard, K. M., Cowie, C. C., Lessem, S. E., Saydah, S. H., Menke, A., Geiss, L. S., Orchard, T. J., Rolka, D. B., & Imperatore, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a2 · Cited by 512
Paciaroni, M., Agnelli, G., Corea, F., Ageno, W., Alberti, A., Lanari, A., Caso, V., Micheli, S., Bertolani, L., Venti, M. P., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.510321 · Cited by 508
Markus, H. S., Hayter, E., Levi, C. R., Feldman, A. L., Venables, G. S., Norris, J., Peycke, J., Willson, M., Hicks, C., Madigan, J., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70018-9 · Cited by 500
Siontis, K. C., Zhang, X., Eckard, A., Bhave, N. M., Schaubel, D. E., He, K., Tilea, A. M., Stack, A. G., Balkrishnan, R., Yao, X., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035418 · Cited by 499
Services, C. F. M. A. M., Billioux, A., Verlander, K., Services, C. F. M. A. M., Anthony, S., Services, C. F. M. A. M., Alley, D., & Services, C. F. M. A. M. (2017) · NAM Perspectives · doi:10.31478/201705b · Cited by 492
Shinohara, Y., Katayama, Y., Uchiyama, S., Yamaguchi, T., Handa, S., Matsuoka, K., Ohashi, Y., Tanahashi, N., Yamamoto, H., Genka, C., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70198-8 · Cited by 487
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 487
Olesen, J. B., Torp-Pedersen, C. T., Hansen, M. L., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 484
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study
Kleindorfer, D., Panagos, P. D., Pancioli, A., Khoury, J. C., D, B. M. K. M., Woo, D., Schneider, A. T., Alwell, K., Jauch, E. C., Miller, R., et al. (2005) · Stroke · doi:10.1161/01.str.0000158917.59233.b7 · Cited by 473
Self-citationFibromuscular Dysplasia: State of the Science and Critical Unanswered Questions
Olin, J. W., Gornik, H. L., Bacharach, J. M., Biller, J., Fine, L. J., Gray, B. H., Gray, W. A., Gupta, R. G., Hamburg, N. M., Katzen, B. T., et al. (2014) · Circulation · doi:10.1161/01.cir.0000442577.96802.8c · Cited by 473
Novel epidemiological features of moyamoya disease
Baba, T., Houkin, K., & Kuroda, S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.130666 · Cited by 464
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study
Rolfs, A., Böttcher, T., Zschiesche, M., Morris, P., WINCHESTER, B. G., Bauer, P. O., Walter, U., Mix, E., Löhr, M. J., HARZER, K., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67635-0 · Cited by 463
LeBlanc, E. S., Patnode, C. D., Webber, E. M., Redmond, N., Rushkin, M., & O’Connor, E. A. (2018) · JAMA · doi:10.1001/jama.2018.7777 · Cited by 463
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Antiretroviral Treatment of Adult HIV Infection
Günthard, H. F., Aberg, J. A., Eron, J. J., Hoy, J., Telenti, A., Benson, C. A., Burger, D. M., Cahn, P. E., Gallant, J. E., Glesby, M. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.8722 · Cited by 448
Pristipino, C., Sievert, H., D’Ascenzo, F., Mas, J., Meier, B., Scacciatella, P., Hildick‐Smith, D., Gaïta, F., Toni, D., Kyrle, P. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy649 · Cited by 448
Kenet, G., Lütkhoff, L. K., Albisetti, M., Bernard, T. J., Bonduel, M. M., Brandão, L. R., Chabrier, S., Chan, A. K. C., deVeber, G., Fiedler, B. J., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.913673 · Cited by 446
First International Consensus on the diagnosis and management of fibromuscular dysplasia
Gornik, H. L., Persu, A., Adlam, D., Aparicio, L. S., Azizi, M., Boulanger, M., Bruno, R. M., de Leeuw, P. W., Fendrikova-Mahlay, N., Froehlich, J. B., et al. (2019) · Vascular Medicine · doi:10.1177/1358863x18821816 · Cited by 446
Socioeconomic Status and Stroke
Addo, J., Ayerbe, L., Mohan, K. M., Crichton, S. L., Sheldenkar, A., Chen, R., Wolfe, C. D. A., & McKevitt, C. (2012) · Stroke · doi:10.1161/strokeaha.111.639732 · Cited by 444
Individual behavioural counselling for smoking cessation
Lancaster, T., & Stead, L. F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001292.pub3 · Cited by 436
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
Sarić, M., Armour, A. C., Arnaout, M. S., Chaudhry, F. A., Grimm, R. A., Kronzon, I., Landeck, B. F., Maganti, K., Michelena, H. I., & Tolstrup, K. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.09.011 · Cited by 433
Qaseem, A., Wilt, T. J., Kansagara, D. L., Horwitch, C., Barry, M. J., & Forciea, M. A. (2018) · Annals of Internal Medicine · doi:10.7326/m17-0939 · Cited by 432
The natural history of lacunar infarction: the Oxfordshire Community Stroke Project.
Bamford, J., Sandercock, P. A., Jones, L., & Warlow, C. (1987) · Stroke · doi:10.1161/01.str.18.3.545 · Cited by 431
Vaitkus, P. T., & Barnathan, E. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90409-t · Cited by 430
Jebb, S. A., Ahern, A. L., Olson, A. D., Aston, L. M., Holzapfel, C., Stoll, J., Amann-Gassner, U., Simpson, A. E., Fuller, N. R., Pearson, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61344-5 · Cited by 422
Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease
Rees, K., Takeda, A., Martin, N., Ellis, L., Wijesekara, D., Vepa, A., Das, A., Hartley, L., & Stranges, S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009825.pub3 · Cited by 422
Mitral Annular Calcification and the Risk of Stroke in an Elderly Cohort
Benjamin, E. J., Plehn, J. F., D’Agostino, R. B., Belanger, A. J., Comai, K., Fuller, D. L., Wolf, P. A., & Levy, D. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270602 · Cited by 421
Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study
Suk, S.-H., Sacco, R. L., Boden-Albala, B., Cheun, J. F., Pittman, J. G., Elkind, M. S., & Paik, M. C. (2003) · Stroke · doi:10.1161/01.str.0000075294.98582.2f · Cited by 420
Wong, K. S., Chen, C., Fu, J., Chang, H. M., Suwanwela, N. C., Huang, Y. N., Han, Z., Tan, K. S., Ratanakorn, D., Chollate, P., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70060-0 · Cited by 419
Heiro, M., Nikoskelainen, J., Engblom, E., Kotilainen, E., Marttila, R., & Kotilainen, P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2781 · Cited by 415
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1712572 · Cited by 415
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M. D., Jafri, S. M., Krol, W. F., O’Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 413
Immune mechanisms in medium and large-vessel vasculitis
Weyand, C. M., & Goronzy, J. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.161 · Cited by 412
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411
The effects of socioeconomic status on stroke risk and outcomes
Marshall, I. J., Wang, Y., Crichton, S. L., McKevitt, C., Rudd, A. G., & Wolfe, C. D. A. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00200-8 · Cited by 408
Prospective Study of Markers of Hemostatic Function With Risk of Ischemic Stroke
Folsom, A. R., Rosamond, W. D., Shahar, E., Cooper, L. S., Aleksic, N., Nieto, F. J., Rasmussen, M. L., & Wu, K. K. (1999) · Circulation · doi:10.1161/01.cir.100.7.736 · Cited by 407
Cleland, J. G. F., Findlay, I., Jafri, S. M., Sutton, G. C., Falk, R. H., Bulpitt, C., Prentice, C. R. M., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Smith, E. E., Saposnik, G., Biessels, G. J., Doubal, F. N., Fornage, M., Gorelick, P. B., Greenberg, S. M., Higashida, R. T., Kasner, S. E., & Seshadri, S. (2017) · Stroke · doi:10.1161/str.0000000000000116 · Cited by 404
Mazzolai, L., Aboyans, V., Ageno, W., Agnelli, G., Alatri, A., Bauersachs, R., Brekelmans, M. P. A., Büller, H. R., Elias, A., Farge, D., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx003 · Cited by 402
Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate
Hoffman, G. S., Leavitt, R. Y., Kerr, G. S., Rottem, M., Sneller, M. C., & Fauci, A. S. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370420 · Cited by 399
Patra, J., Taylor, B., Irving, H. M., Roerecke, M., Baliunas, D. O., Mohapatra, S., & Rehm, J. T. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-258 · Cited by 397
Harrington, R. A., Califf, R. M., Balamurugan, A., Brown, N., Benjamin, R. M., Braund, W. E., Hipp, J. S., Konig, M., Sánchez, E., & Maddox, K. E. J. (2020) · Circulation · doi:10.1161/cir.0000000000000753 · Cited by 393
Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke
Hackam, D. G., & Spence, J. D. (2007) · Stroke · doi:10.1161/strokeaha.106.475525 · Cited by 389
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
Ware, R. E., & Helms, R. W. (2012) · Blood · doi:10.1182/blood-2011-11-392340 · Cited by 385
Kamel, H., Longstreth, W. T., Tirschwell, D., Kronmal, R. A., Broderick, J. P., Palesch, Y. Y., Meinzer, C., Dillon, C., Ewing, I., Spilker, J. A., et al. (2018) · International Journal of Stroke · doi:10.1177/1747493018799981 · Cited by 380
Self-citationGiant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992
Drake, C. G., & Peerless, S. J. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.87.2.0141 · Cited by 376
Asia Pacific Cohort Studies Collaboration (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh163 · Cited by 375
Physical fitness training for stroke patients
Saunders, D. H., Sanderson, M. F., Hayes, S., Johnson, L. G., Kramer, S. F., Carter, D. D., Jarvis, H. L., Brazzelli, M. G., & Mead, G. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003316.pub7 · Cited by 373
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
Pegelow, C. H., Adams, R. J., McKie, V. C., Abboud, M. R., Berman, B., Miller, S. T., Olivieri, N. F., Vichinsky, E. P., Wang, W. C., & Brambilla, D. J. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70204-0 · Cited by 370
Cerebrovascular Complications of the Use of the Crack Form of Alkaloidal Cocaine
Levine, S. R., Brust, J. C. M., Futrell, N., Ho, K. L., Blake, D., Millikan, C. H., Brass, L. M., Fayad, P. B., Schultz, L. R., Selwa, J. F., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009133231102 · Cited by 366
Kamal, A. H., Tefferi, A., & Pruthi, R. K. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.7.864 · Cited by 365
Andréoli, L., Chighizola, C. B., Banzato, A., Pons‐Estel, G., de Jesús, G. R., Erkan, D., & ACTION, O. B. O. A. (2013) · Arthritis Care & Research · doi:10.1002/acr.22066 · Cited by 363
Bays, H. E., Ballantyne, C. M., Kastelein, J. J., Isaacsohn, J. L., Braeckman, R. A., & Soni, P. N. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.04.015 · Cited by 358
Systematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358
Folsom, A. R., Rasmussen, M. L., Chambless, L. E., Howard, G., Cooper, L. S., Schmidt, M. I., & HEISS, G. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1077 · Cited by 356
Is increased blinking a form of blepharospasm?
(2013) · CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) · doi:10.1212/wnl · Cited by 355
How Physically Active Are People Following Stroke? Systematic Review and Quantitative Synthesis
Fini, N. A., Holland, A. E., Keating, J. L., Simek, J., & Bernhardt, J. A. (2017) · Physical Therapy · doi:10.1093/ptj/pzx038 · Cited by 354
Rothwell, P. M., Cook, N. R., Gaziano, J. M., Price, J. F., Belch, J. F. F., Roncaglioni, M. C., Morimoto, T., & Mehta, Z. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31133-4 · Cited by 353
Mazlumzadeh, M., Hunder, G. G., Easley, K. A., CALAMIA, K. T., Matteson, E. L., Griffing, W. L., Younge, B. R., Weyand, C. M., & Goronzy, J. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22163 · Cited by 345
Wiggins, B. S., Saseen, J. J., Page, R. L., II, Reed, B. N., Sneed, K., Kostis, J. B., Lanfear, D. E., Virani, S. S., & Morris, P. B. (2016) · Circulation · doi:10.1161/cir.0000000000000456 · Cited by 345
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1808848 · Cited by 345
Obstructive Sleep Apnea Is a Risk Factor for Death in Patients With Stroke
Sahlin, C., Sandberg, O., Gustafson, Y., Bucht, G., Carlberg, B., Stenlund, H. C., & Franklin, K. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.70 · Cited by 343
Gotoh, F., Tohgi, H., Hirai, S., Terashi, A., Fukuuchi, Y., Otomo, E., Shinohara, Y., Itoh, E., Matsuda, T., Sawada, T., et al. (2000) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2000.7216 · Cited by 343
Further Evidence Relating Mitral-Valve Prolapse to Cerebral Ischemic Events
Barnett, H. J. M., Boughner, D. R., Taylor, D. W., Cooper, P. E., Kostuk, W. J., & Nichol, P. M. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001173020303 · Cited by 343
Westover, A. N., Mcbride, S., & Haley, R. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.495 · Cited by 341
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial
Feldmann, E. G., Wilterdink, J. L., Kosinski, A. S., Lynn, M., Chimowitz, M. I., Sarafin, J.-A. M., Smith, H. H., Nichols, F. T., Rogg, J. M., Cloft, H. J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261488.05906.c1 · Cited by 339
High risk of thromboemboli early after bioprosthetic cardiac valve replacement
Heras, M., Chesebro, J. H., Fuster, V., Penny, W. J., Grill, D. E., Bailey, K. R., Danielson, G. K., Orszulak, T. A., Pluth, J. R., Puga, F. J., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00563-6 · Cited by 335
Qaseem, A., Holty, J.-E. C., Owens, D. K., Dallas, P., Starkey, M., & Shekelle, P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-00704 · Cited by 335
American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12514 · Cited by 334
Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms
Anson, J. A., Lawton, M. T., & Spetzler, R. F. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.84.2.0185 · Cited by 334
Migraine and structural changes in the brain
Bashir, A., Lipton, R. B., Ashina, S., & Ashina, M. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cb32 · Cited by 331
Passive smoking as well as active smoking increases the risk of acute stroke
Bonita, R., Duncan, J. R., Truelsen, T. C., Jackson, R., & Beaglehole, R. (1999) · Tobacco Control · doi:10.1136/tc.8.2.156 · Cited by 331
Qaseem, A., Humphrey, L. L., Fitterman, N., Starkey, M., & Shekelle, P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00009 · Cited by 329
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
Walters, M. C., Patience, M., Leisenring, W. M., Rogers, Z. R., Aquino, V. M., Buchanan, G. R., Roberts, I. A. G., Yeager, A. M., Hsu, L. L.-Y., Adamkiewicz, T. V., et al. (2001) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2001.v7.pm11787529 · Cited by 324
Ordi-Ros, J., Sáez-Comet, L., Pérez-Conesa, M., Vidal, X., Riera-Mestre, A., Castro-Salomó, A., Cuquet-Pedragosa, J., Ortiz-Santamaria, V., Mauri-Plana, M., Solé, C., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0291 · Cited by 324
Russell, M., Goldberg, H. I., Hodson, A., Kim, H., Halus, J., Reivich, M., & Schwartz, E. (1984) · Blood · doi:10.1182/blood.v63.1.162.bloodjournal631162 · Cited by 323
Arima, H., Chalmers, J. P., Woodward, M., Anderson, C. S., Rodgers, A., Davis, S. M., MacMahon, S. W., & Neal, B. C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226212.34055.86 · Cited by 323
Alexander, M. J., Zauner, A., Chaloupka, J. C., Baxter, B., Callison, R. C., Gupta, R. G., Song, S. S., Yu, W., on behalf of the WEAVE Trial Investigators, Feng, L., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023996 · Cited by 322
The relationship between smoking and stroke
Biqi, P., Jin, X., Liu, J. L., Qiu, S., Zheng, Q., & Pan, M. (2019) · Medicine · doi:10.1097/md.0000000000014872 · Cited by 315
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction
Kalstad, A. A., Myhre, P. L., Laake, K., Tveit, S. H., Schmidt, E. B., Smith, P., Nilsen, D. W. T., Tveit, A., Fagerland, M. W., Solheim, S., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052209 · Cited by 311
Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis
Kwon, S. U., Cho, Y., Koo, J., Bae, H., Lee, Y.-S., Hong, K., Lee, J. H., & Kim, J. S. (2005) · Stroke · doi:10.1161/01.str.0000157667.06542.b7 · Cited by 306
Fisher, D. P., Johnson, E., Haneuse, S., Arterburn, D., Coleman, K. J., O’Connor, P. J., O’Brien, R., Bogart, A., Theis, M. K., Anau, J., et al. (2018) · JAMA · doi:10.1001/jama.2018.14619 · Cited by 305
Caceres, B. A., Streed, C. G., Corliss, H. L., Lloyd‐Jones, D. M., Matthews, P. A., Mukherjee, M., Poteat, T., Rosendale, N., & Ross, L. M. (2020) · Circulation · doi:10.1161/cir.0000000000000914 · Cited by 303
Determinants of early recurrence of cerebral infarction. The Stroke Data Bank.
Sacco, R. L., Foulkes, M. A., Mohr, J. P., Wolf, P. A., Hier, D. B., & Price, T. R. (1989) · Stroke · doi:10.1161/01.str.20.8.983 · Cited by 301
Siddiqui, A. H., Abla, A. A., Kan, P. T. M., Dumont, T. M., Jahshan, S., Britz, G. W., Hopkins, L. N., & Levy, E. I. (2012) · Journal of neurosurgery · doi:10.3171/2012.2.jns111942 · Cited by 300
Surgical management of infective endocarditis associated with cerebral complications
Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., & Omae, T. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70038-2 · Cited by 299
Duration of Diabetes and Risk of Ischemic Stroke
Banerjee, C., Moon, Y. P., Paik, M. C., Rundek, T., Mora‐McLaughlin, C., Vieira, J. R., Sacco, R. L., & Elkind, M. S. V. (2012) · Stroke · doi:10.1161/strokeaha.111.641381 · Cited by 299
Hillen, T., Coshall, C., Tilling, K., Rudd, A. G., McGovern, R., & Wolfe, C. D. A. (2003) · Stroke · doi:10.1161/01.str.0000072985.24967.7f · Cited by 298
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Backer, O. D., Dangas, G., Jilaihawi, H., Leipsic, J. A., Terkelsen, C. J., Makkar, R., Kini, A. S., Veien, K. T., Abdel‐Wahab, M., Kim, W., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911426 · Cited by 298
ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
Habel, L. A., Cooper, W. O., Sox, C. M., Chan, K. A., Fireman, B. H., Arbogast, P. G., Cheetham, T. C., Quinn, V. P., Dublin, S., Boudreau, D. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1830 · Cited by 297
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Dayer, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub5 · Cited by 295
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection
Markus, H. S., Levi, C. R., King, A., Madigan, J. B., Norris, J. W., & for the Cervical Artery Dissection in Stroke Study (CADISS) Investigators (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0072 · Cited by 293
Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke
Schwamm, L. H., Reeves, M. J., Pan, W., Smith, E. E., Frankel, M. R., Olson, D., Zhao, X., Peterson, E., & Fonarow, G. C. (2010) · Circulation · doi:10.1161/circulationaha.109.881490 · Cited by 292
Lópes, R. D., Alings, M., Connolly, S. J., Beresh, H., Granger, C. B., Mazuecos, J. B., Boriani, G., Nielsen, J. C., Conen, D., Hohnloser, S. H., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.04.008 · Cited by 288
Puskas, J. D., Gerdisch, M., Nichols, D., Quinn, R. D., Anderson, C. C., Rhenman, B. E., Fermin, L., McGrath, M., Kong, B. K., Hughes, C. G., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.01.004 · Cited by 285
Wachter, R., Gröschel, K., Gelbrich, G., Hamann, G. F., Kermer, P., Liman, J., Seegers, J., Wasser, K., Schulte, A., Jürries, F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30002-9 · Cited by 283
Diamantopoulos, A. P., Haugeberg, G., Lindland, A., & Myklebust, G. (2015) · Lara D. Veeken · doi:10.1093/rheumatology/kev289 · Cited by 282
Aortic Plaque Morphology and Vascular Events
Cohen, A. A., Tzourio, C., Bertrand, B., Chauvel, C., Bousser, M., & Amarenco, P. (1997) · Circulation · doi:10.1161/01.cir.96.11.3838 · Cited by 274
Cancer-associated stroke: Pathophysiology, detection and management (Review)
Dardiotis, E., Aloizou, A., Markoula, S., Siokas, V., Tsarouhas, K., Tzanakakis, G. N., Libra, M., Kyritsis, A. P., Brotis, A. G., Aschner, M., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4669 · Cited by 274
Schermerhorn, M. L., Liang, P., Eldrup-Jørgensen, J., Cronenwett, J. L., Nolan, B. W., Kashyap, V. S., Wang, G. J., Motaganahalli, R. L., & Malas, M. B. (2019) · JAMA · doi:10.1001/jama.2019.18441 · Cited by 270
Sodium Intake and Risk of Death From Stroke in Japanese Men and Women
Nagata, C., Takatsuka, N., Shimizu, N., & Shimizu, H. (2004) · Stroke · doi:10.1161/01.str.0000130425.50441.b0 · Cited by 269
Makin, S., Turpin, S., Dennis, M. S., & Wardlaw, J. M. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303645 · Cited by 268
Li, Y., Huang, T., Zheng, Y., Muka, T., Troup, J., & Hu, F. B. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003768 · Cited by 268
Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women
Kurth, T., Gaziano, J. M., Rexrode, K. M., Kase, C. S., Cook, N. R., Manson, J. E., & Buring, J. E. (2005) · Circulation · doi:10.1161/01.cir.0000161822.83163.b6 · Cited by 267
Jonas, D. E., Amick, H. R., Feltner, C., Weber, R. P., Arvanitis, M., Stine, A., Lux, L., & Harris, R. P. (2017) · JAMA · doi:10.1001/jama.2016.19635 · Cited by 267
Malambo, P., Kengne, A. P., de Villiers, A., Lambert, E. V., & Puoane, T. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166846 · Cited by 265
Newman‐Toker, D. E., Moy, E. M., Valente, E., Coffey, R. M., & Hines, A. L. (2014) · Diagnosis · doi:10.1515/dx-2013-0038 · Cited by 263
Wechsler, L. R., Demaerschalk, B. M., Schwamm, L. H., Adeoye, O. M., Audebert, H. J., Fanale, C. V., Hess, D. C., Majersik, J. J., Nyström, K. V., Reeves, M. J., et al. (2016) · Stroke · doi:10.1161/str.0000000000000114 · Cited by 262
Stroke recurrence within 2 years after ischemic infarction.
Hier, D. B., Foulkes, M. A., Swiontoniowski, M., Sacco, R. L., Gorelick, P. B., Mohr, J. P., Price, T. R., & Wolf, P. A. (1991) · Stroke · doi:10.1161/01.str.22.2.155 · Cited by 255
Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas
Tamin, S. S., Maleszewski, J. J., Scott, C. G., Khan, S., Edwards, W. D., Bruce, C. J., Oh, J. K., Pellikka, P. A., & Klarich, K. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.569 · Cited by 254
Hu, G., Tuomilehto, J. O., Silventoinen, K., Sarti, C., Männistö, S., & Jousilahti, P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1420 · Cited by 252
Doehner, W., Schenkel, J., Anker, S. D., Springer, J., & Audebert, H. J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs340 · Cited by 252
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy
Nagel, M. A., Forghani, B., Mahalingam, R., Wellish, M., Cohrs, R. J., Russman, A., Katzan, I., Lin, R., Gardner, C. J., & Gilden, D. (2007) · Neurology · doi:10.1212/01.wnl.0000258549.13334.16 · Cited by 251
Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial
Parra, O., Sánchez‐Armengol, Á., Bonnin, M., Arboix, A., Campos‐Rodríguez, F., Pérez‐Ronchel, J., Durán‐Cantolla, J., Torre, G. D. L., Marcos, J., de la Peña, M., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00034410 · Cited by 250
Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution
Moyssakis, I. E., Tektonidou, M. G., Vasilliou, V. A., Samarkos, M., Votteas, V., & Moutsopoulos, H. Μ. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.024 · Cited by 249
Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke
Ovbiagele, B. I., Diener, H. C., Yusuf, S., Martin, R. H., Cotton, D., Vinisko, R., Donnan, G. A., Bath, P. M., & for the PROFESS Investigators (2011) · JAMA · doi:10.1001/jama.2011.1650 · Cited by 248
Steffel, J., Verhamme, P. B., Potpara, T., Albaladejo, P., Antz, M., Desteghe, L., Hæusler, K. G., Oldgren, J., Reinecke, H., Roldán, V., et al. (2018) · EP Europace · doi:10.1093/europace/euy054 · Cited by 248
Arnott, C., Li, Q., Kang, A., Neuen, B. L., Bompoint, S., Lam, C. S. P., Rodgers, A., Mahaffey, K. W., Cannon, C. P., Perkovic, V., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014908 · Cited by 247
Wensing, M., Wollersheim, H. C. H., & Grol, R. P. T. M. (2006) · Implementation Science · doi:10.1186/1748-5908-1-2 · Cited by 246
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
Robinson, A. A., Trankle, C. R., Eubanks, G. C., Schumann, C. L., Thompson, P., Wallace, R. L., Gottiparthi, S., Ruth, B. K., Kramer, C. M., Salerno, M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0652 · Cited by 246
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
Avezum, Á., Lópes, R. D., Schulte, P. J., Lanas, F. T., Gersh, B. J., Hanna, M., Pais, P., Erol, Ç., Díaz, R., Bahit, M. C., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014807 · Cited by 245
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Seiffge, D. J., Werring, D. J., Paciaroni, M., Dawson, J., Warach, S. J., Milling, T. J., Engelter, S. T., Fischer, U., & Norrving, B. G. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30356-9 · Cited by 245
Post-stroke antihypertensive treatment study. A preliminary result.
Pats, & Collaborating (1995) · PubMed · Cited by 243
Cigarette Smoking and Other Risk Factors for Silent Cerebral Infarction in the General Population
Howard, G., Wagenknecht, L. E., Cai, J., Cooper, L. S., Kraut, M. A., & Toole, J. F. (1998) · Stroke · doi:10.1161/01.str.29.5.913 · Cited by 240
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack
Pan, Y., Elm, J. J., Li, H., Easton, J. D., Wang, Y., Farrant, M., Meng, X., Kim, A. S., Zhao, X., Meurer, W. J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2531 · Cited by 239
Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study.
Hart, R. G., Coull, B. M., & Hart, D. (1983) · Stroke · doi:10.1161/01.str.14.5.688 · Cited by 239
Howard, G., Roubin, G. S., Jansen, O., Hendrikse, J., Halliday, A. W., Fraedrich, G., Eckstein, H., Calvet, D., Bulbulia, R. A., Bonati, L. H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01309-4 · Cited by 236
Monagle, P., Cochrane, A. D., Roberts, R. E., Manlhiot, C., Weintraub, R. G., Szechtman, B., Hughes, M. L., Andrew, M. E., & McCrindle, B. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.061 · Cited by 234
Prevalence of sleep-disordered breathing after stroke and TIA: A meta-analysis
Seiler, A., Camilo, M., Korostovtseva, L., Haynes, A. G., Brill, A.-K., Horvath, T., Egger, M., & Bassetti, C. L. (2019) · Neurology · doi:10.1212/wnl.0000000000006904 · Cited by 234
Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program.
Burchfiel, C. M., Curb, J. D., Rodríguez, B. L., Abbott, R. D., Chiu, D., & Yano, K. (1994) · Stroke · doi:10.1161/01.str.25.5.951 · Cited by 233
Pérez-Gómez, F., Alegría, E., Berjón, J., Iriarte, J. A., Zumalde, J., Salvador, A., & Mataix, L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.084 · Cited by 232
Germain, D. P., Elliot, P. M., Falissard, B., Fomin, V. V., Hilz, M. J., Jovanović, A., Kantola, I. M., Linhart, A., Mignani, R., Namdar, M., et al. (2019) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2019.100454 · Cited by 232
Mérie, C., Køber, L., Olsen, P. S., Andersson, C., Gislason, G., Jensen, J. S., & Torp-Pedersen, C. T. (2012) · JAMA · doi:10.1001/jama.2012.54506 · Cited by 230
Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke
Kitagawa, K., Yamamoto, Y., Arima, H., Maeda, T., Sunami, N., Kanzawa, T., 江口, 和., Kamiyama, K., Minematsu, K., Ueda, S., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2167 · Cited by 230
Acar, J., Iung, B., Boissel, J., Samama, M. M., Michel, P. L., Teppe, J. P., Pony, J. C., Breton, H., Thomas, D., Isnard, R., et al. (1996) · Circulation · doi:10.1161/01.cir.94.9.2107 · Cited by 227
Sitting and Activity Time in People With Stroke
English, C., Healy, G. N., Coates, A. M., Lewis, L. K., Olds, T., & Bernhardt, J. A. (2015) · Physical Therapy · doi:10.2522/ptj.20140522 · Cited by 226
Chiavaroli, L., Nishi, S. K., Khan, T. A., Braunstein, C. R., Glenn, A. J., Mejia, S. B., Rahelić, D., Kahleová, H., Salas-Salvadó, J., Jenkins, D. J. A., et al. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.05.004 · Cited by 226
Natural history of vertebrobasilar dolichoectasia
Passero, S. G., & Rossi, S. (2007) · Neurology · doi:10.1212/01.wnl.0000286947.89193.f3 · Cited by 226
Guichard, J.-B., & Nattel, S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.033 · Cited by 226
Hemorrhagic Transformation in Acute Ischemic Stroke
Jaillard, A. S., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
Ryan, C. M., Bayley, M. T., Green, R., Murray, B. J., & Bradley, T. D. (2011) · Stroke · doi:10.1161/strokeaha.110.597468 · Cited by 225
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia
Kadian‐Dodov, D. L., Gornik, H. L., Gu, X., Froehlich, J. B., Bacharach, J. M., Chi, Y., Gray, B. H., Jaff, M. R., Kim, E., Mace, P. D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.044 · Cited by 224
Efficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., TOUTOUZAS, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 223
LV Thrombus Detection by Routine Echocardiography
Weinsaft, J. W., Kim, H. W., Crowley, A. L., Klem, I., Shenoy, C., Assche, L. M. V., Brosnan, R. B., Shah, D. J., Velazquez, E. J., Parker, M. A., et al. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.03.017 · Cited by 222
Cervical Arterial Dissections and Association With Cervical Manipulative Therapy
Biller, J., Sacco, R. L., Albuquerque, F. C., Demaerschalk, B. M., Fayad, P. B., Long, P. H., Noorollah, L. D., Panagos, P. D., Schievink, W. I., Schwartz, N. E., et al. (2014) · Stroke · doi:10.1161/str.0000000000000016 · Cited by 222
Haussen, D. C., Grossberg, J. A., Bouslama, M., Pradilla, G., Belagaje, S. R., Bianchi, N. A., Allen, J. W., Frankel, M., & Nogueira, R. G. (2017) · Stroke · doi:10.1161/strokeaha.117.019020 · Cited by 219
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
Pre-Operative Risk Factors of Bleeding and Stroke During Left Ventricular Assist Device Support
Boyle, A. J., Jorde, U. P., Sun, B., Park, S. J., Milano, C. A., Frazier, O. H., Sundareswaran, K. S., Farrar, D. J., & Russell, S. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1656 · Cited by 216
Effect of pre-diabetes on future risk of stroke: meta-analysis
Lee, M., Saver, J. L., Hong, K., Song, S. S., Chang, K., & Ovbiagele, B. I. (2012) · BMJ · doi:10.1136/bmj.e3564 · Cited by 216
Sandberg, O., Franklin, K. A., Bucht, G., Eriksson, S., & Gustafson, Y. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00070301 · Cited by 216
Senaratna, C. V., Perret, J. L., Matheson, M. C., Lodge, C. J., Lowe, A. J., Cassim, R., Russell, M. A., Burgess, J. A., Hamilton, G. S., & Dharmage, S. C. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.04.001 · Cited by 214
de Bruijn, S. F. T. M., Agema, W. R. P., Lammers, G. J., van der Wall, E. E., Wolterbeek, R., Holman, E. R., Bollen, E. L. E. M., & Bax, J. J. (2006) · Stroke · doi:10.1161/01.str.0000241064.46659.69 · Cited by 214
Extracranial Carotid and Vertebral Artery Dissection: A Review
Redekop, G. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100008556 · Cited by 214
Guerrero, M. E., Vemulapalli, S., Xiang, Q., Wang, D. D., Eleid, M. F., Cabalka, A. K., Sandhu, G. S., Salinger, M. H., Russell, H. M., Greenbaum, A. B., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008425 · Cited by 213
Healey, J. S., Gladstone, D. J., Swaminathan, B., Eckstein, J., Mundl, H., Epstein, A. E., Hæusler, K. G., Mikulík, R., Kasner, S. E., Toni, D., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0617 · Cited by 209
Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study
Gardener, H. E., Sacco, R. L., Rundek, T., Battistella, V., Cheung, Y. K., & Elkind, M. S. V. (2020) · Stroke · doi:10.1161/strokeaha.119.028806 · Cited by 209
Epidemiology of Takayasu arteritis
Önen, F., & Akkoç, N. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.05.034 · Cited by 208
Practice advisory update summary: Patent foramen ovale and secondary stroke prevention
Messe, S. R., Gronseth, G., Kent, D. M., Kizer, J. R., Homma, S., Rosterman, L. R., Carroll, J. D., Ishida, K., Sangha, N. S., & Kasner, S. E. (2020) · Neurology · doi:10.1212/wnl.0000000000009443 · Cited by 208
Dual antiplatelet therapy in stroke and ICAS
Liu, L., Wong, K. S., Leng, X., Pu, Y., Wang, Y., Jing, J., Zou, X., Pan, Y., Wang, A., Meng, X., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001972 · Cited by 207
Device Closure of Patent Foramen Ovale After Stroke
Kent, D. M., Dahabreh, I. J., Ruthazer, R., Furlan, A. J., Reisman, M., Carroll, J. D., Saver, J. L., Smalling, R. W., Jüni, P., Mattle, H. P., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.023 · Cited by 207
Research works printed but not linked: 11
- 10.1148/radiol.10100804 · DOI
- 10.1001/jama.1988.03720070025028 · DOI
- 10.1161/JAHA.117.00785 · DOI
- Inzucchi, SE, Docherty, K, Kober, L, Kosiborod, MN, Martinez, F. Effect of dapagliflozin on the incidence of diabetes: a prespecified exploratory analysis from DAPA-HF. Paper presented at: American Diabetes Association 80th Scientific Sessions; 2020; virtual.
- 10.1161/JAHA.116.00472 · DOI
- 10.1056/NEJMoa1910355 · DOI
- 10.1136/bmj.324.7329.7 · DOI
- 10.1182/blood.V63.1.162.162 · DOI
- 10.1043/0003-9985(2002)126<0182:AFIAHI>2.0.CO;2 · DOI
- Ubogu, EE, Zaidat, OO. Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study. J Neurol Neurosurg Psychiatry. 2004;75:22–26.
- Lawrence, K, Keleher, T. Structural Racism. Paper presented at: Race and Public Policy Conference; November 11–13, 2004; Berkeley, CA.
Cited by
Sorted by citations
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Greenberg, S. M., Ziai, W., Cordonnier, C., Dowlatshahi, D. D., Francis, B. A., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., et al. (2022) · Stroke · doi:10.1161/str.0000000000000407 · Cited by 1,876
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixidó‐Turà, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., Backer, J. F. A. D., Déglise, S., Corte, A. D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 1,313
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y., Zhang, H., Pang, X., Chen, L., Zhou, L., Chen, M., Tian, D., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 997
Metadata
- Authors
- Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., Lennon, O., Meschia, J. F., Nguyen, T. N., Pollak, P. M., Santangeli, P., Sharrief, A. Z., Smith, S. C., Turan, T. N., & Williams, L. S.
- ORCID
- Venue
- Stroke
- Published
- 2021-07
- Volume
- 52
- Issue
- 7
- Pages
- e364-e467
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W3164908038
- Semantic Scholar
- 18bb9d19bdfe54d5d1289c0a74fbcb410e3e1b6d
- Cited by
- 3,237
- References
- 892
- Citations by year
- 2026: 653 · 2025: 670 · 2024: 778 · 2023: 618 · 2022: 432 · 2021: 82
- FWCI
- 72.98
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-28)
- Open access
- bronze
- doi.org
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Congress of Neurological Surgeons
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- secondary stroke prevention, stroke recurrence, transient ischemic attack, stroke risk factors
- MeSH terms
- Clinical Decision-Making, American Heart Association, Ischemic Attack, Transient, Humans, United States, Practice Guidelines as Topic, Stroke, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
